[Articles] Early middle meningeal artery embolisation plus standard treatment versus standard treatment alone for chronic subdural haematoma in France (OTEMACS): a randomised, open-label, controlled trial

Author profile image Aggregator
0 comments
In patients with symptomatic chronic subdural haematoma, early adjunctive MMA embolisation reduced reoperation without increasing mortality or major complications. However, because enrolment stopped early outside the prespecified efficacy boundary and the primary analysis excluded patients without an assessable outcome, the nominal p value is not confirmatory, and the benefit might be overestimated. These findings require further confirmation before routine adoption of early postoperative MMA embolisation.

Source: The Lancet Neurology - Current Issue Published 30 Nov 2026 Imported 19 Nov 2026 Relevancy: Not reviewed

Read the article